Institutional investors purchased a net $2.9 million shares of EXAS during the quarter ended September 2017 and now own 84.47% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 2.8 Million shares of Exact Sciences Corp
BLACKROCK FUND ADVISORS Bought 592.1 Thousand shares of Exact Sciences Corp
FRONTIER CAPITAL MANAGEMENT CO. ... Bought 568.1 Thousand shares of Exact Sciences Corp